glp-1 drugs safe How medications are transforming diabetes and weight loss treatment As GLP-1 Use Expands, Long-Term

and its subsequent exploitation in the form of glucagon-like peptide 1 (GLP-1) receptor agonists (RA) has been a therapeutic success story for Type 2 diabetes (T2D) and obesity management

The populations and transition probabilities were derived by linking the Australian Diabetes Registry (1.1 million people with type 2 diabetes) to hospital admissions databases, the National Death Index and the ESKD Registry using data from 2010 to 2019

Regular follow-ups allow your provider to review your progress and make necessary adjustments

You may be eating the same, moving your body, doing everything "right," and still watching your body change

To the best of our knowledge, this meta-analysis is the first to evaluate the effects and safety of SGLT2i and GLP-1RAs as first-line therapy for T2DM with low cardiovascular risk

If you have a first-degree relative with medullary thyroid carcinoma or multiple endocrine neoplasia type 2, inform your healthcare provider before starting GLP-1 medications